Aspyra (OTCMKTS:APYI – Get Free Report) and Precipio (NASDAQ:PRPO – Get Free Report) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their analyst recommendations, dividends, earnings, valuation, profitability, risk and institutional ownership.
Profitability
This table compares Aspyra and Precipio’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Aspyra | N/A | N/A | N/A |
| Precipio | -5.50% | -10.07% | -6.71% |
Insider & Institutional Ownership
10.5% of Precipio shares are held by institutional investors. 23.9% of Aspyra shares are held by insiders. Comparatively, 16.9% of Precipio shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
Analyst Ratings
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Aspyra | 0 | 0 | 0 | 0 | 0.00 |
| Precipio | 1 | 0 | 0 | 0 | 1.00 |
Volatility and Risk
Aspyra has a beta of 2.29, meaning that its stock price is 129% more volatile than the S&P 500. Comparatively, Precipio has a beta of 1.12, meaning that its stock price is 12% more volatile than the S&P 500.
Valuation and Earnings
This table compares Aspyra and Precipio”s revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Aspyra | N/A | N/A | N/A | N/A | N/A |
| Precipio | $18.53 million | 2.35 | -$4.29 million | ($0.82) | -30.40 |
Aspyra has higher earnings, but lower revenue than Precipio.
Summary
Aspyra beats Precipio on 5 of the 8 factors compared between the two stocks.
About Aspyra
Aspyra Inc. provides health care products and services for the laboratory and imaging marketplaces. It offers engineered workflow solutions that include software, interfaces, hardware, and professional services to various markets comprising specialty labs, reference labs, clinics, hospitals, imaging centers, and orthopedic practices. The company was formerly known as Creative Computer Applications Inc. and changed its name to Aspyra Inc. in November 2005. Aspyra Inc. was founded in 1978 and is headquartered in Jacksonville, Florida.
About Precipio
Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; and HemeScreen, a suite of robust genetic diagnostic panels. It offers biomarker testing and clinical project services to bio-pharma customers. The company is based in New Haven, Connecticut.
Receive News & Ratings for Aspyra Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspyra and related companies with MarketBeat.com's FREE daily email newsletter.
